Wellington Management Group
INDV icon

Wellington Management Group’s Indivior Pharmaceuticals INDV Stock Holding History

Wellington Management Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
45,581
-3,548
-7% -$129K ﹤0.01% 1645
2026
Q1 		$1.5M Sell
49,129
-3,273
-6% -$108K ﹤0.01% 1603
2025
Q4 		$1.88M Sell
52,402
-908
-2% -$27.7K ﹤0.01% 1611
2025
Q3 		$1.29M Buy
+53,310
New +$1.12M ﹤0.01% 1727

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's INDV Position: Q2 2026 in Review

Wellington Management Group reduced its Indivior Pharmaceuticals (INDV) stake by 7.2% in Q2 2026, selling an estimated $129K and leaving 45,581 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Wellington Management Group first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.88M in Q4 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Wellington Management Group held 45,581 shares of Indivior Pharmaceuticals worth $1.87M as of Q2 2026.
  • Wellington Management Group sold 3,548 Indivior Pharmaceuticals shares in Q2 2026, an estimated $129K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1645 holding.
  • Wellington Management Group first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Wellington Management Group's Indivior Pharmaceuticals position peaked at $1.88M in Q4 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.